Zimmer Biomet Holdings (ZBH) EBITDA Margin (2009 - 2026)
Zimmer Biomet Holdings' quarterly EBITDA Margin came in at 17.88% in Q1 2026, up 257.0% year-on-year from 5.01% in Q1 2025, and up 159.74% quarter-over-quarter from 6.89% in Q4 2025.
Zimmer Biomet Holdings has reported EBITDA Margin for 18 years, with the latest figure at 17.88% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 257.0% year-over-year to 17.88%; the trailing twelve-month figure through Mar 2026 stood at 14.02% (down 302.0% YoY), and the FY2025 full-year result was 13.34%, down 340.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 17.88%, up from 6.89% in the prior quarter.
- The five-year high for EBITDA Margin was 19.23% in Q4 2024, with the low at 1.55% in Q4 2022.
- Average EBITDA Margin over 5 years is 14.62%, with a median of 15.32% recorded in 2024.
- Year-over-year, EBITDA Margin jumped 1981 bps in 2023 and tumbled 1234 bps in 2025.
- Tracing ZBH's EBITDA Margin over 5 years: stood at 1.55% in 2022, then soared by 1277 bps to 18.26% in 2023, then rose by 5 bps to 19.23% in 2024, then slumped by 64 bps to 6.89% in 2025, then jumped by 160 bps to 17.88% in 2026.
- The last three EBITDA Margin figures came in at 17.88% (Q1 2026), 6.89% (Q4 2025), and 17.55% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 17.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.88% |
| Dec 31, 2025 | 6.89% |
| Sep 30, 2025 | 17.55% |
| Jun 30, 2025 | 14.44% |
| Mar 31, 2025 | 15.31% |
| Dec 31, 2024 | 19.23% |
| Sep 30, 2024 | 15.32% |
| Jun 30, 2024 | 18.09% |
| Mar 31, 2024 | 14.07% |
| Dec 31, 2023 | 18.26% |
| Sep 30, 2023 | 15.20% |
| Jun 30, 2023 | 17.63% |
| Mar 31, 2023 | 17.88% |
| Dec 31, 2022 | -1.55% |
| Sep 30, 2022 | 14.69% |
| Jun 30, 2022 | 15.76% |
| Mar 31, 2022 | 11.93% |
| Dec 31, 2021 | 7.53% |
| Sep 30, 2021 | 14.42% |
| Jun 30, 2021 | 12.75% |
| Mar 31, 2021 | 0.43% |
| Dec 31, 2020 | 19.74% |
| Sep 30, 2020 | 15.51% |
| Jun 30, 2020 | -14.00% |
| Mar 31, 2020 | -25.56% |
| Dec 31, 2019 | 15.84% |
| Sep 30, 2019 | 12.99% |
| Jun 30, 2019 | 10.29% |
| Mar 31, 2019 | 17.73% |
| Dec 31, 2018 | -38.17% |
| Sep 30, 2018 | 12.16% |
| Jun 30, 2018 | 14.74% |
| Mar 31, 2018 | 15.12% |
| Dec 31, 2017 | -1.94% |
| Sep 30, 2017 | 11.65% |
| Jun 30, 2017 | 14.37% |
| Mar 31, 2017 | 17.65% |
| Dec 31, 2016 | 8.87% |
| Sep 30, 2016 | 10.67% |
| Jun 30, 2016 | 10.42% |
| Mar 31, 2016 | 12.89% |
| Dec 31, 2015 | 11.04% |
| Sep 30, 2015 | 6.58% |
| Jun 30, 2015 | -11.31% |
| Mar 31, 2015 | 23.79% |
| Dec 31, 2014 | 18.51% |
| Sep 30, 2014 | 23.07% |
| Jun 30, 2014 | 22.06% |
| Mar 31, 2014 | 25.84% |
| Dec 31, 2013 | 28.07% |
| Sep 30, 2013 | 19.71% |
| Jun 30, 2013 | 17.99% |
| Mar 31, 2013 | 26.18% |
| Dec 31, 2012 | 16.98% |
| Sep 30, 2012 | 24.32% |
| Jun 30, 2012 | 26.84% |
| Mar 31, 2012 | 25.91% |
| Dec 31, 2011 | 17.24% |
| Sep 30, 2011 | 25.85% |
| Jun 30, 2011 | 22.78% |
| Mar 31, 2011 | 26.64% |
| Dec 31, 2010 | 10.83% |
| Sep 30, 2010 | 28.15% |
| Jun 30, 2010 | 21.57% |
| Mar 31, 2010 | 27.67% |
| Dec 31, 2009 | 21.54% |
| Sep 30, 2009 | 20.91% |
| Jun 30, 2009 | 29.07% |
| Mar 31, 2009 | 28.19% |